Abortion : Termination of Early Pregnancy with RU-486 (Mifepristone).

Describes background of FDA approval and conditions of use for the abortion drug mifepristone, also known as RU-486, and legislative issues that may include restrictions on program funding and drug use. Considers FDA approval of the drug in 2000 and potential impact of RU-486 use.

Bibliographic Details

Corporate Authors:	Library of Congress. Congressional Research Service, ProQuest (Firm)
Format:	eBook
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], 2001.
Series:	U.S. Congressional Research.
Subjects:	Abortion. Family planning. Medical laws and legislation. Electronic books.
Online Access:	Connect to the full text of this electronic book